EUVIMEDEUVIMED entdecken
Crossref

Relationship Between Clarithromycin Minimum Inhibitory Concentrations and Treatment Responses in Mycobacterium avium Complex Pulmonary Disease

Joong-Yub Kim iD, Hyeontaek Hwang, DaHae Yim, Yunhee Choi iD, Taek Soo Kim iD, Jake Whang iD, Nakwon Kwak iD, Jae-Joon Yim

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciae546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Joong-Yub Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Clarithromycin, Mycobacterium avium Complex, Mycobacterium avium-intracellulare Infection, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mycobacterium avium complex pulmonary disease (MAC-PD) is a chronic lung condition with rapidly increasing prevalence worldwide. Macrolides like azithromycin and clarithromycin are the backbone of long-term antibiotic therapy for progressive MAC-PD. The impact of minimum inhibitory concentrations (MICs), especially within the susceptible range, for macrolides on treatment responses remains unclear.

Methods

We analyzed adult patients who started treatment for MAC-PD between 1 March 2009 and 1 March 2022 at Seoul National University Hospital. Patients were categorized into 4 groups according to the clarithromycin MICs of their causative strains at treatment initiation. Logistic regression was employed to evaluate the impact of clarithromycin MICs on the likelihood of microbiological cure. Companion drugs and their MICs, alongside clinical characteristics like age, sex, body mass index, cavity presence, acid-fast bacilli smear positivity, causative species, and erythrocyte sedimentation rate were adjusted in multivariable analysis.

Results

Four-hundred thirty-six patients (median age, 65 years; 34% men) were included. Microbiological cure rates were 51.8%, 51.9%, 50.0%, and 18.2% for patients with clarithromycin MICs ≤0.5, 1–2, 4–8, and ≥32 µg/mL, respectively (P = .181). No significant differences in microbiological cure rates were observed across varying levels of clarithromycin MICs within the susceptible range (≤8 µg/mL). Relative to patients with clarithromycin-susceptible strains, patients with MICs ≥32 µg/mL had an odds ratio of 0.25 for achieving microbiological cure (95% confidence interval [CI]: 0.06–1.07; P = .06).

Conclusions

Treatment responses were comparable among patients with strains having clarithromycin MICs within the susceptible range but were likely to be worse for patients with strains having MICs ≥32 µg/mL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClarithromycinMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionAnti-Bacterial AgentsLung DiseasesHumansMaleFemaleAgedMicrobial Sensitivity TestsMiddle AgedTreatment OutcomeAdultAged, 80 and overRetrospective Studies

Stichwörter der Autor:innen

azithromycinclarithromycinmicrobiological cureminimum inhibitory concentrationnontuberculous mycobacteria

Substanzen

ClarithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Microbiology, Harvard Medical School, Boston, United States.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Joong-Yub Kim, Yunhee Choi, Taek Soo Kim, Jake Whang, Nakwon Kwak

Zitieren

APA

Kim, J. Y., Hwang, H., Yim, D., Choi, Y., Kim, T. S., Whang, J., Kwak, N., & Yim, J. J. (2025). Relationship Between Clarithromycin Minimum Inhibitory Concentrations and Treatment Responses in Mycobacterium avium Complex Pulmonary Disease. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae546

Vancouver

Kim JY, Hwang H, Yim D, Choi Y, Kim TS, Whang J, et al. Relationship Between Clarithromycin Minimum Inhibitory Concentrations and Treatment Responses in Mycobacterium avium Complex Pulmonary Disease. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciae546

BibTeX
@article{Kim2025,
  author = {Kim, Joong-Yub and Hwang, Hyeontaek and Yim, DaHae and Choi, Yunhee and Kim, Taek Soo and Whang, Jake and Kwak, Nakwon and Yim, Jae-Joon},
  title = {Relationship Between Clarithromycin Minimum Inhibitory Concentrations and Treatment Responses in Mycobacterium avium Complex Pulmonary Disease},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciae546}
}
Kostenlos starten →